|
MCM4 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.71445146547012E-14 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.48245868306185E-13 |
| Normal-vs-Stage2 |
4.515500E-03 |
| Normal-vs-Stage3 |
2.0238000053574E-08 |
| Normal-vs-Stage4 |
4.1025999997224E-07 |
| Stage1-vs-Stage2 |
3.355600E-02 |
| Stage1-vs-Stage3 |
8.542200E-01 |
| Stage1-vs-Stage4 |
8.672200E-01 |
| Stage2-vs-Stage3 |
7.772300E-02 |
| Stage2-vs-Stage4 |
4.641700E-02 |
| Stage3-vs-Stage4 |
7.844000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.67743596790615E-12 |
| Normal-vs-AfricanAmerican |
1.117320E-03 |
| Normal-vs-Asian |
3.07470000016075E-07 |
| Caucasian-vs-AfricanAmerican |
3.722000E-01 |
| Caucasian-vs-Asian |
8.327600E-01 |
| AfricanAmerican-vs-Asian |
5.753000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.31490000291279E-08 |
| Normal-vs-Female |
1.67110769666579E-12 |
| Male-vs-Female |
1.966200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.81188397618826E-13 |
| Normal-vs-Age(41-60Yrs) |
2.35340003040818E-09 |
| Normal-vs-Age(61-80Yrs) |
3.37000000016907E-07 |
| Normal-vs-Age(81-100Yrs) |
1.440570E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.468500E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.011780E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.547600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.469000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.046400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.768800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.373190E-01 |
| Classical-VS-Follicular |
8.36890001743029E-09 |
| Classical-VS-Other |
2.938400E-01 |
| Classical-VS-Normal |
1.62447832963153E-12 |
| Tall-VS-Follicular |
2.99730000041798E-07 |
| Tall-VS-Other |
7.861800E-02 |
| Tall-VS-Normal |
2.32169999891951E-08 |
| Follicular-VS-Other |
3.680400E-01 |
| Follicular-VS-Normal |
8.701500E-02 |
| Other-VS-Normal |
1.885570E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.33659999734803E-08 |
| Normal-vs-N1 |
2.26009999999555E-05 |
| N0-vs-N1 |
2.434800E-01 |
|
|
